FDA Inspection 1160439 — Rutgers State Of NJ IRB
The FDA completed an inspection of Rutgers State Of NJ IRB on Dec 9, 2021 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 9, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newark, NJ (United States)
Additional Details
IRB